Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
Medicine
|
July 10, 2010
Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients
Marzia Varettoni, Alessandro Corso, Federica Cocito, et al.
European Journal of Haematology
|
June 13, 2009
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived
Alessandro Corso, Marzia Varettoni, Silvia Mangiacavalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 13, 2006
Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience
Patrizia Zappasodi, Alessandro Corso, Catherine Klersy, et al.
Journal of Medical Cases
|
June 12, 2025
High-Sensitivity Flow Cytometric Detection of a Small Circulating Population of Nodal T-Follicular Helper Cell Lymphoma Angioimmunoblastic Type Cells
Arianna Gatti, Silvia Franceschetti, Valentina Speziale, et al.
Cancer
|
May 17, 2005
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect
Alessandro Corso, Eleonora Ferretti, Monia Lunghi, et al.
Plos One
|
October 8, 2013
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis
Alessandro Corso, Silvia Mangiacavalli, Federica Cocito, et al.
Critical Reviews in Oncology/Hematology
|
February 13, 2022
Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel
Corrado Girmenia, Michele Cavo, Alessandro Corso, et al.
Blood Reviews
|
January 27, 2019
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
Corrado Girmenia, Michele Cavo, Massimo Offidani, et al.
Transfusion
|
February 6, 2008
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients
Patrizia Zappasodi, Anna Maria Nosari, Cesare Astori, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 3, 2008
Immune-mediated neuropathies in myeloma patients treated with bortezomib
Sabrina Ravaglia, Alessandro Corso, Giovanni Piccolo, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
Medicine
|
July 10, 2010
Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients
Marzia Varettoni, Alessandro Corso, Federica Cocito, et al.
European Journal of Haematology
|
June 13, 2009
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived
Alessandro Corso, Marzia Varettoni, Silvia Mangiacavalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 13, 2006
Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience
Patrizia Zappasodi, Alessandro Corso, Catherine Klersy, et al.
Journal of Medical Cases
|
June 12, 2025
High-Sensitivity Flow Cytometric Detection of a Small Circulating Population of Nodal T-Follicular Helper Cell Lymphoma Angioimmunoblastic Type Cells
Arianna Gatti, Silvia Franceschetti, Valentina Speziale, et al.
Cancer
|
May 17, 2005
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect
Alessandro Corso, Eleonora Ferretti, Monia Lunghi, et al.
Plos One
|
October 8, 2013
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis
Alessandro Corso, Silvia Mangiacavalli, Federica Cocito, et al.
Critical Reviews in Oncology/Hematology
|
February 13, 2022
Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel
Corrado Girmenia, Michele Cavo, Alessandro Corso, et al.
Blood Reviews
|
January 27, 2019
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
Corrado Girmenia, Michele Cavo, Massimo Offidani, et al.
Transfusion
|
February 6, 2008
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients
Patrizia Zappasodi, Anna Maria Nosari, Cesare Astori, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 3, 2008
Immune-mediated neuropathies in myeloma patients treated with bortezomib
Sabrina Ravaglia, Alessandro Corso, Giovanni Piccolo, et al.
Page
of 6